Lv1
30 积分 2021-09-02 加入
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
1小时前
待确认
Tailoring Escalation Adjuvant Therapy for Early-Stage Triple-Negative Breast Cancer in the CBCSG010 Clinical Trial Biomarker Analysis
1个月前
已关闭
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2个月前
已关闭
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
2个月前
已完结
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
2个月前
已完结
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
4个月前
已完结
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
4个月前
已完结
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
4个月前
已完结
6th and 7th International Consensus Guidelines for the management of advanced breast cancer (ABC Guidelines 6 and 7)
4个月前
已完结
[Child-Pugh classification in liver cirrhosis]
5个月前
已关闭
皖公网安备34019202002308
